← Leaderboards
Christopher Michael McNair
Thomas Jefferson University
$357,405
Attributed
$714,810
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $357.4K · FY2020–21$500K$375K$250K$125K$0
'20
'21
Funding mix
By agency
NIH$714,810 · 1
By mechanism
R01$714,810 · 1
Top collaborators
- William K. Kelly2 shared
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Renato V. Iozzo$16,721,043
- Marja T Nevalainen$4,195,518
- Agnieszka Witkiewicz$7,548,076
- Walter John Curran$19,392,586
- Steven B McMahon$11,125,471
Others in their field
Other Emerging Leaders on “Advanced Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Chanza Baytop · Westat, Inc.$271,217,917
- Kimberly Smith · Ppd Development Lp$116,656,661
- Klaus Romero · Critical Path Institute$88,602,036
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$59,913,818
Research focus
Advanced DiseaseAndrogen ReceptorAndrogen SuppressionAdvanced Prostate CancerBindingBiological MarkersBiopsyBypassBaseCastration Resistant Prostate CancerCdk4 GeneCell CycleCell Cycle RegulationCellsChromatinClinical DataClinical ManagementClinical TrialsCastrationCollaborationsComplementComplexCyclin D1Cyclin-Dependent Kinases